中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 12
Dec.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(12): 2869-2873

Performance of controlled attenuation parameter measured by FibroScan in the diagnosis of nonalcoholic fatty liver disease and its association with traditional Chinese medicine syndrome types

DOI: 10.3969/j.issn.1001-5256.2021.12.026
  • 1.

    The First Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou 450000, China

  • 2.

    Department of Hepatology and Spleen-Stomach, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China

Research funding:

Special Key Project of Henan Province Traditional Chinese Medicine Scientific Research (2014ZY01012);

Research on the Optimal Treatment of Non-alcoholic Steatohepatitis Based on the Combination of Disease and Syndrome (2018JDZX005)

  • Received Date: 2021-04-29
  • Accepted Date: 2021-05-21
  • Published Date: 2021-12-20
    Abstract
  •   Objective  To investigate the application value of controlled attenuation parameter (CAP) of hepatocyte steatosis measured by FibroScan in the diagnosis and traditional Chinese medicine (TCM) syndrome differentiation of nonalcoholic fatty liver disease (NAFLD).  Methods  A retrospective analysis was performed for related data of 364 patients with NAFLD who attended The First Affiliated Hospital of Henan University of Traditional Chinese Medicine from January 2017 to December 2019, including basic information (age, sex, and body mass index [BMI]), CAP measured by FibroScan, ultrasound findings of the liver, gallbladder, spleen, and pancreas, liver function parameters, and blood lipid parameters. TCM syndrome differentiation was performed based on the information obtained by four diagnostic methods, and then the patients were divided into liver depression and spleen deficiency group, damp turbidity and stagnation group, damp-heat accumulation group, intermingled phlegm and blood stasis group, and spleen-kidney deficiency group. The association of CAP, color Doppler ultrasound findings, liver function parameters, blood lipid parameters, and BMI with TCM syndrome was analyzed. A one-way analysis of variance was used for comparison of normally distributed continuous data between multiple groups, and the least significant difference t-test was used for further comparison between two groups; the Kruskal-Wallis H rank sum test with multiple sets of independent samples was used for comparison of non-normally distributed continuous data between multiple groups and further comparison between two groups. The chi-square test or Kruskal-Wallis H rank sum test was used for comparison of categorical data between multiple groups and further comparison between two groups. A Spearman's rank correlation analysis was used to investigate the correlation between CAP and ultrasound grading.  Results  Among the 364 patients with NAFLD, 169 had the syndrome of liver depression and spleen deficiency, 71 had the syndrome of damp turbidity and stagnation, 60 had the syndrome of damp-heat accumulation, 41 had the syndrome of intermingled phlegm and blood stasis, and 23 had the syndrome of spleen-kidney deficiency. There was a significant difference in CAP value between the different syndrome types (F=14.839, P < 0.001), and further comparison between two groups showed that the spleen-kidney deficiency group and the intermingled phlegm and blood stasis group had a significantly higher CAP value than the liver depression and spleen deficiency group, the damp turbidity and stagnation group, and the damp-heat accumulation group (all P < 0.05). There was a significant difference in ultrasound grading between the different syndrome types (χ2=22.947, P < 0.001); the liver depression and spleen deficiency group mainly had a mild grade (40.2%), the damp turbidity and stagnation group and the damp-heat accumulation group mainly had a moderate grade (53.5% and 53.3%, respectively), and the intermingled phlegm and blood stasis group and the spleen-kidney deficiency group mainly had a severe grade (68.3% and 43.5%, respectively). CAP was positively correlated with the severity of fatty liver (r=0.431, P < 0.001). The spleen-kidney deficiency group and the intermingled phlegm and blood stasis group had significantly higher levels of alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transpeptidase, and BMI than the other three groups (all P < 0.001).  Conclusion  Association is observed between CAP and the TCM syndrome types of NAFLD, and patients with the syndrome of spleen-kidney deficiency and the syndrome of intermingled phlegm and blood stasis have a higher CAP value than those with the other syndrome types. CAP has similar efficiency to color Doppler ultrasound in the diagnosis of NAFLD.

     

    • FullText(HTML)
  • loading
    • References(17)
  • [1]
    XUE R, FAN JG. Brief introduction of an international expert consensus statement: A new definition of metabolic associated fatty liver disease[J]. J Clin Hepatol, 2020, 36(6): 1224-1227. DOI: 10.3969/j.issn.1001-5256.2020.06.007.

    薛芮, 范建高. 代谢相关脂肪性肝病新定义的国际专家共识简介[J]. 临床肝胆病杂志, 2020, 36(6): 1224-1227. DOI: 10.3969/j.issn.1001-5256.2020.06.007.
    [2]
    Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on TCM diagnosis and treatment of nonalcoholic fatty liver disease (2017)[J]. J Clin Hepatol, 2017, 33(12): 2270-2274. DOI: 10.3969/j.issn.1001-5256.2017.12.002.

    中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗专家共识意见(2017)[J]. 临床肝胆病杂志, 2017, 33(12): 2270-2274. DOI: 10.3969/j.issn.1001-5256.2017.12.002.
    [3]
    National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association, Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: A 2018 update[J]. J Clin Hepatol, 2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.

    中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.
    [4]
    CHEN JN, CHEN AP, PAN Q, et al. Influential factors and clinical value of controlled attenuation parameters in the evaluation of hepatic steatosis using FibroScan®[J]. Chin Hepatol, 2016, 21(10): 805-809. DOI: 10.3969/j.issn.1008-1704.2016.10.001.

    陈建能, 陈爱萍, 潘勤, 等. FibroScan®实施受控衰减参数检测肝脂肪变的影响因素及应用价值分析[J]. 肝脏, 2016, 21(10): 805-809. DOI: 10.3969/j.issn.1008-1704.2016.10.001.
    [5]
    CHEN GY, PAN Q, SHEN F, et al. Reproducibility study of Fibroscan for liver controlled attenuator parameters measurement[J]. Chin Hepatol, 2015, 20(11): 855-857. DOI: 10.3969/j.issn.1008-1704.2015.11.005.

    陈光榆, 潘勤, 沈峰, 等. Fibroscan检测肝脏受控衰减参数的重复性研究[J]. 肝脏, 2015, 20(11): 855-857. DOI: 10.3969/j.issn.1008-1704.2015.11.005.
    [6]
    de LÉDINGHEN V, VERGNIOL J, CAPDEPONT M, et al. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations[J]. J Hepatol, 2014, 60(5): 1026-1031. DOI: 10.1016/j.jhep.2013.12.018.
    [7]
    PU K, WANG Y, BAI S, et al. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: A systematic review and meta-analysis[J]. BMC Gastroenterol, 2019, 19(1): 51. DOI: 10.1186/s12876-019-0961-9.
    [8]
    ANDRADE P, RODRIGUES S, RODRIGUES-PINTO E, et al. Diagnostic accuracy of controlled attenuation parameter for detecting hepatic steatosis in patients with chronic liver disease[J]. GE Port J Gastroenterol, 2017, 24(4): 161-168. DOI: 10.1159/000453364.
    [9]
    TONG GD, XING YF, ZHOU XL, et al. Diagnosis and treatment scheme of Ganpi (non-alcoholic steatohepatitis)[J/CD]. Chin J Liver Dis(Electronic Edition), 2021, 13(1): 1-9. DOI: 10.3969/j.issn.1674-7380.2021.01.001.

    童光东, 邢宇锋, 周晓玲, 等. 肝癖(非酒精性脂肪性肝炎)诊疗方案[J/CD]. 中国肝脏病杂志(电子版), 2021, 13(1): 1-9. DOI: 10.3969/j.issn.1674-7380.2021.01.001.
    [10]
    MA YN, LIU JC. Research progress in the noninvasive quantitative diagnosis of hepatic steatosis using controlled attenuation parameters[J]. Chin J Gastroenterol Hepatol, 2020, 29(11): 1309-1312, 1316. DOI: 10.3969/j.issn.1006-5709.2020.11.023.

    马亚楠, 刘近春. 受控衰减参数无创定量诊断肝脂肪变性的研究进展[J]. 胃肠病学和肝病学杂志, 2020, 29(11): 1309-1312, 1316. DOI: 10.3969/j.issn.1006-5709.2020.11.023.
    [11]
    VUPPALANCHI R, SIDDIQUI MS, van NATTA ML, et al. Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease[J]. Hepatology, 2018, 67(1): 134-144. DOI: 10.1002/hep.29489.
    [12]
    KARLAS T, PETROFF D, SASSO M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis[J]. J Hepatol, 2017, 66(5): 1022-1030. DOI: 10.1016/j.jhep.2016.12.022.
    [13]
    WANG YH, ZHANG HO. Clinical research on evaluating nonalcoholic fatty liver and its TCM syndrome type by fat attenuation index[J]. Chin J Integr Tradit West Med Liver Dis, 2017, 27(1): 16-19. DOI: 10.3969/j.issn.1005-0264.2017.01.006.

    王玉衡, 张海鸥. 应用脂肪衰减参数评价非酒精性脂肪肝与中医证型关系[J]. 中西医结合肝病杂志, 2017, 27(1): 16-19. DOI: 10.3969/j.issn.1005-0264.2017.01.006.
    [14]
    ZHANG T, DONG SJ, HAN YJ. Application of fat attenuation parameter to the diagnosis of fatty liver of different Chinese medicine syndromes[J]. Henan Tradit Chin Med, 2016, 36(11): 1940-1942. DOI: 10.16367/j.issn.1003-5028.2016.11.0780.

    张婷, 董淑娟, 韩艳俊. 脂肪衰减参数在不同中医证型脂肪肝诊断中的应用[J]. 河南中医, 2016, 36(11): 1940-1942. DOI: 10.16367/j.issn.1003-5028.2016.11.0780.
    [15]
    LI ZJ, WU PC, ZHOU S. Effect observation on treating nonalcoholic fatty liver with Tiaogan Yunpi Huazhuo decoction and electroacupuncture[J]. J Changchun Univ Chin Med, 2021, 37(1): 103-107. DOI: 10.13463/j.cnki.cczyy.2021.01.028.

    李枝锦, 吴平财, 周山. 调肝运脾化浊方联合电针治疗非酒精性脂肪肝[J]. 长春中医药大学学报, 2021, 37(1): 103-107. DOI: 10.13463/j.cnki.cczyy.2021.01.028.
    [16]
    ZHANG XL, LIU MJ. Study on optimum scheme of establishing rat obesity model based on modern literature[J]. J Changchun Univ Chin Med, 2019, 35(1): 131-135. DOI: 10.13463/j.cnki.cczyy.2019.01.039.

    张晓林, 刘明军. 基于现代文献探索大鼠肥胖模型建立的优选方案研究[J]. 长春中医药大学学报, 2019, 35(1): 131-135. DOI: 10.13463/j.cnki.cczyy.2019.01.039.
    [17]
    ZHU YB, WANG Q, WU CY, et al. Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity[J]. J Chin Integr Med, 2010, 8(11): 1023-1028. DOI: 10.3736/jcim20101104.

    朱燕波, 王琦, 吴承玉, 等. 18805例中国成年人中医体质类型与超重和肥胖关系的Logistic回归分析[J]. 中西医结合学报, 2010, 8(11): 1023-1028. DOI: 10.3736/jcim20101104.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (363) PDF downloads(25) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return